204 related articles for article (PubMed ID: 37456868)
1. Network neighborhood operates as a drug repositioning method for cancer treatment.
Cüvitoğlu A; Isik Z
PeerJ; 2023; 11():e15624. PubMed ID: 37456868
[TBL] [Abstract][Full Text] [Related]
2. NMSDR: Drug repurposing approach based on transcriptome data and network module similarity.
Ünsal Ü; Cüvitoğlu A; Turhan K; Işık Z
Mol Inform; 2023 Mar; 42(3):e2200077. PubMed ID: 36411244
[TBL] [Abstract][Full Text] [Related]
3. A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer.
Chen HR; Sherr DH; Hu Z; DeLisi C
BMC Med Genomics; 2016 Jul; 9(1):51. PubMed ID: 27475327
[TBL] [Abstract][Full Text] [Related]
4. Drug repositioning using drug-disease vectors based on an integrated network.
Lee T; Yoon Y
BMC Bioinformatics; 2018 Nov; 19(1):446. PubMed ID: 30463505
[TBL] [Abstract][Full Text] [Related]
5. Computational drug repositioning using meta-path-based semantic network analysis.
Tian Z; Teng Z; Cheng S; Guo M
BMC Syst Biol; 2018 Dec; 12(Suppl 9):134. PubMed ID: 30598084
[TBL] [Abstract][Full Text] [Related]
6. NetPro: Neighborhood Interaction-Based Drug Repositioning via Label Propagation.
Huang Y; Bin Y; Zeng P; Lan W; Zhong C
IEEE/ACM Trans Comput Biol Bioinform; 2023; 20(3):2159-2169. PubMed ID: 37018341
[TBL] [Abstract][Full Text] [Related]
7. MD-Miner: a network-based approach for personalized drug repositioning.
Wu H; Miller E; Wijegunawardana D; Regan K; Payne PRO; Li F
BMC Syst Biol; 2017 Oct; 11(Suppl 5):86. PubMed ID: 28984195
[TBL] [Abstract][Full Text] [Related]
8. Computational drug repositioning through heterogeneous network clustering.
Wu C; Gudivada RC; Aronow BJ; Jegga AG
BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S6. PubMed ID: 24564976
[TBL] [Abstract][Full Text] [Related]
9. DMAP: a connectivity map database to enable identification of novel drug repositioning candidates.
Huang H; Nguyen T; Ibrahim S; Shantharam S; Yue Z; Chen JY
BMC Bioinformatics; 2015; 16 Suppl 13(Suppl 13):S4. PubMed ID: 26423722
[TBL] [Abstract][Full Text] [Related]
10. A bidirectional drug repositioning approach for Parkinson's disease through network-based inference.
Rakshit H; Chatterjee P; Roy D
Biochem Biophys Res Commun; 2015 Feb; 457(3):280-7. PubMed ID: 25576361
[TBL] [Abstract][Full Text] [Related]
11. A Novel Drug Repositioning Approach Based on Integrative Multiple Similarity Measures.
Yan C; Feng L; Wang W; Wang J; Zhang G; Luo J
Curr Mol Med; 2020; 20(6):442-451. PubMed ID: 31729291
[TBL] [Abstract][Full Text] [Related]
12. Integrating LINCS Data to Evaluate Cancer Transcriptome Modifying Potential of Small-molecule Compounds for Drug Repositioning.
Zhao Y; Liu Y; Bai H
Comb Chem High Throughput Screen; 2021; 24(9):1340-1350. PubMed ID: 33109034
[TBL] [Abstract][Full Text] [Related]
13. Drug Repositioning to Accelerate Drug Development Using Social Media Data: Computational Study on Parkinson Disease.
Zhao M; Yang CC
J Med Internet Res; 2018 Oct; 20(10):e271. PubMed ID: 30309833
[TBL] [Abstract][Full Text] [Related]
14. Systems biology based drug repositioning for development of cancer therapy.
Turanli B; Altay O; Borén J; Turkez H; Nielsen J; Uhlen M; Arga KY; Mardinoglu A
Semin Cancer Biol; 2021 Jan; 68():47-58. PubMed ID: 31568815
[TBL] [Abstract][Full Text] [Related]
15. Hybrid attentional memory network for computational drug repositioning.
He J; Yang X; Gong Z; Zamit L
BMC Bioinformatics; 2020 Dec; 21(1):566. PubMed ID: 33297947
[TBL] [Abstract][Full Text] [Related]
16. Drug repositioning in SLE: crowd-sourcing, literature-mining and Big Data analysis.
Grammer AC; Ryals MM; Heuer SE; Robl RD; Madamanchi S; Davis LS; Lauwerys B; Catalina MD; Lipsky PE
Lupus; 2016 Sep; 25(10):1150-70. PubMed ID: 27497259
[TBL] [Abstract][Full Text] [Related]
17. Guiding Drug Repositioning for Cancers Based on Drug Similarity Networks.
Qin S; Li W; Yu H; Xu M; Li C; Fu L; Sun S; He Y; Lv J; He W; Chen L
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768566
[TBL] [Abstract][Full Text] [Related]
18. Computational Drug Repositioning with Random Walk on a Heterogeneous Network.
Luo H; Wang J; Li M; Luo J; Ni P; Zhao K; Wu FX; Pan Y
IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(6):1890-1900. PubMed ID: 29994051
[TBL] [Abstract][Full Text] [Related]
19. MNBDR: A Module Network Based Method for Drug Repositioning.
Chen HG; Zhou XH
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33375395
[TBL] [Abstract][Full Text] [Related]
20. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
